Biomarkers: Tool to identify the Women at increased stroke risk

The Women's Health Initiative hormone trials identified a 44% increase in ischemic stroke risk with combination estrogen plus progestin and a 39% increase with estrogen alone. We undertook a case-control biomarker study to elucidate underlying mechanisms, and to potentially identify women who would be at lower or higher risk for stroke with postmenopausal hormone therapy (HT).

 

    Related Conference of Biomarkers: Tool to identify the Women at increased stroke risk

    June 15-16, 2026

    5th International Conference on Clinical Nutrition & Dietetics

    Zurich, Switzerland
    July 20-21, 2026

    33rd European Nutrition and Dietetics Conference

    Amsterdam, Netherlands
    July 20-21, 2026

    9th World Congress on Food and Nutrition

    Paris, France
    August 24-25, 2026

    25th International Congress on Nutrition and Health

    Paris, France
    August 27-28, 2026

    25th World Congress on Nutrition and Food Chemistry

    Berlin, Germany
    September 14-15, 2026

    19th World Congress on Food Chemistry and Food Microbiology

    Barcelona, Spain
    October 28-29, 2026

    6th Global Congress on Nutrition and Food sciences

    Amsterdam, Netherlands
    November 16-17, 2026

    7th International conference on Probiotics, Prebiotics, Synbiotics & Gut Nutrition

    San Francisco, USA
    November 26-27, 2026

    8th World Summit on Health Nutrition

    Paris, France
    May 03-04, 2027

    31st World Congress on Nutrition and Food Sciences

    Paris, France

    Biomarkers: Tool to identify the Women at increased stroke risk Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in